4-Sep-2026
TipRanks (Wed, 2-Sep 8:10 AM ET)
Analysts Offer Insights on Healthcare Companies: Phibro Animal Health (PAHC) and Phreesia (PHR)
TipRanks (Mon, 31-Aug 6:20 AM ET)
Business Wire (Wed, 26-Aug 4:20 PM ET)
Business Wire (Wed, 19-Aug 4:30 PM ET)
Phibro Animal Health Corporation Declares Quarterly Dividend
Business Wire (Tue, 28-Jul 4:10 PM ET)
Market Chameleon (Fri, 19-Dec 3:42 AM ET)
Phibro Animal Health Corp is a world-wide diversified animal health and mineral nutrition company. It strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. It develop, manufacture and market products for food animals including poultry, beef and dairy cattle, swine, aquaculture and dogs. It has three segments Animal Health, Mineral Nutrition, and Performance Products. Majority of revenue comes from Animal Health segment. Animal health products are anti-bacterials, anticoccidials, nutritional specialty products, and vaccines, and vaccine adjuvants that help improve the animal's health.
Phibro Animal Health - Class A trades on the NASDAQ stock market under the symbol PAHC.
As of September 4, 2026, PAHC stock price declined to $38.25 with 165,246 million shares trading.
PAHC has a beta of -0.31, meaning it tends to be less sensitive to market movements. PAHC has a correlation of 0.00 to the broad based SPY ETF.
PAHC has a market cap of $1.55 billion. This is considered a Small Cap stock.
Last quarter Phibro Animal Health - Class A reported $397 million in Revenue and $.85 earnings per share. This beat revenue expectation by $21 million and exceeded earnings estimates by $.13.
In the last 3 years, PAHC traded as high as $60.08 and as low as $9.40.
The top ETF exchange traded funds that PAHC belongs to (by Net Assets): VTI, XPH, VXF, XSMO, IJT.
PAHC has underperformed the market in the last year with a return of -0.9%, while SPY returned +19.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PAHC shares. However, PAHC has outperformed the market in the last 3 month and 2 week periods, returning +16.1% and +5.6%, while SPY returned +2.0% and +0.6%, respectively. This indicates PAHC has been having a stronger performance recently.
PAHC support price is $37.40 and resistance is $39.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PAHC shares will trade within this expected range on the day.